API | diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine Report issue

Vaccine Approved ^FDA

AACT MeSH

Active Ingredient History

NOW

DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine | diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -haemophilus influenzae type b conjugate vaccine | diphtheria-tetanus- pertussis, hepatitis b and hib combination vaccines | diphtheria,tetanus,pertussis+polio+hepatitis b+hib | diphtheria toxoid / filamentous haemagglutinin / hepatitis b surface antigen / pertussis toxoid / tetanus toxoid / haemophilus influenzae type b polysaccharide / polyribosylribitol phosphate conjugated to tetanus protein / type 1 (mahoney) / type 2 (mef-1) / type 3 (saukett) | diphtheria toxoid / tetanus toxoid / bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae types 2 and 3 / hepatitis b surface antigen produced in yeast cells / poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) produced in vero cells/ haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein. | diphtheria toxoid / tetanus toxoid / bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis-b surface antigen / poliovirus (inactivated) (type 1 (mahoney strain), type 2 (mef-1 strain), type 3 (saukett strain)) | diphtheria toxoid / tetanus toxoid / bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis b surface antigen / poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)) / haemophilus influenzae type-b polysaccharide | diphtheria toxoid / tetanus toxoid / inactivated bordetella pertussis / hepatitis b surface antigen (rdna) / haemophilus influenzae type b polysaccharide | diphtheria toxoid / tetanus toxoid / pertussis toxoid / pertussis haemagglutin filamentous / pertactin / hepatitisb recombinant surface antigen | diphtheria toxoid /tetanus toxoid / two-component acellular pertussis(pertussis toxoidand filamentous haemagglutinin ) /inactivated poliomyelitis virus types 1,2 and 3 /haemophilus influenzae type-b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein / hepatitis-b surface antigen | dtap(5)-ipv-hib vaccine | dtap-ipv-hib conjugate vaccine | dtap-ipv-hib-hbv conjugate vaccine | dtap-ipv-hib-hbv vaccine | infanrix hexa | pediacel | pediarix | purified diphtheria toxoid / purified tetanus toxoid / purified pertussis toxoid / purified pertussis filamentous haemagglutinin / hepatitis b surface antigen / inactivated type 1 poliovirus (mahoney) / inactivated type 2 poliovirus (mef 1) / inactivated type 3 poliovirus (saukett) / haemophilus influenzae type b polysaccharide

Organizations (22)

Research & Development (22)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (35)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (35)

Bacterial Infections (Phase 3)

BCG Vaccine (Phase 4)

Chickenpox (Phase 3)

Diphtheria (Phase 4)

Diphtheria-Tetanus-acellular Pertussis Vaccines (Phase 4)

Drug Therapy, Combination (Phase 4)

Fever (Phase 4)

Haemophilus Infections (Phase 3)

Haemophilus influenzae type b (Phase 4)

Healthy Volunteers (Phase 3)

Hematopoietic Stem Cell Transplantation (Phase 3)

Hepatitis B (Phase 4)

Immunity (Phase 4)

Immunization (Phase 3)

Infant (Phase 4)

Measles (Phase 3)

Meningitis, Meningococcal (Phase 3)

Meningococcal Infections (Phase 3)

Mumps (Phase 3)

Neisseria meningitidis (Phase 3)

Neoplasms (Phase 2)

Pertussis Vaccine (Phase 4)

Pneumococcal Infections (Phase 3)

Pneumococcal Vaccines (Phase 4)

Pneumonia, Staphylococcal (Phase 3)

Poliomyelitis (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)

Rotavirus Infections (Phase 3)

Rotavirus Vaccines (Phase 3)

Rubella (Phase 3)

Streptococcal Infections (Phase 4)

Tetanus (Phase 4)

Vaccines (Phase 4)

Virus Diseases (Phase 3)

Whooping Cough (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 62
# of Trial Organizations: 22

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue